HR 2577
108th Congress
House
Foreign Trade and International Finance
Commerce
Congress
Congressional investigations
Congressional reporting requirements
Drug industry
Drugs
Economics and Public Finance
Health
International Affairs
Nontariff trade barriers
Prescription pricing
Price regulation
Trade negotiations
To require the Comptroller General to conduct a study and submit to Congress a report on price controls of foreign governments on pharmaceuticals.
Introduced: June 24, 2003
See on congress.gov
Everywhere this bill has been
4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 2, 2003
Referred to the Subcommittee on Trade.
Jul 1, 2003
Referred to the Subcommittee on Health.
Jun 24, 2003
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jun 24, 2003
Introduced in House
Plain-English summary
Requires the Comptroller General to conduct a study and report to Congress on: (1) the impact of price controls on pharmaceuticals by foreign governments, including the impact on market access for U.S. pharmaceuticals and on pharmaceutical prices for U.S. consumers; and (2) the extent to which negotiations conducted by the U.S. Trade Representative under the Bipartisan Trade Promotion Authority Act of 2002 facilitate the elimination of such price controls.
What's happening now
Referred to the Subcommittee on Trade.
Committees of jurisdiction
4
Cosponsors
1